NF-κB/p52 augments ETS1 binding genome-wide to promote glioma progression
Gliomas are highly invasive and chemoresistant cancers, making them challenging to treat. Chronic inflammation is a key driver of glioma progression as it promotes aberrant activation of inflammatory pathways such as NF-κB signalling, which drives cancer cell invasion and angiogenesis. NF-κB factors...
| Príomhchruthaitheoirí: | , |
|---|---|
| Rannpháirtithe: | |
| Formáid: | Journal Article |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
2023
|
| Ábhair: | |
| Rochtain ar líne: | https://hdl.handle.net/10356/169293 |